Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose.
about
Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysisCrystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic propertiesDifferentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment.Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explantsComparison of glucose derivatives effects on cartilage degradation.10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furinThe human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.Evaluation of Glucosamine sulfate and Ibuprofen effects in patients with temporomandibular joint osteoarthritis symptom.Commonly Used Dietary Supplements on Coagulation Function during SurgeryA comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individualsPhysiological effects of oral glucosamine on joint health: current status and consensus on future research prioritiesA novel balanced-lethal host-vector system based on glmS.Synthesis and characterization of a new Peptide prodrug of glucosamine with enhanced gut permeability.Individual variability in human blood metabolites identifies age-related differences.Glucosamine and chondroitin for osteoarthritis.The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making.The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial.Modern management of mild-to-moderate joint pain due to osteoarthritis: a holistic approach.What about supplements for osteoarthritis? A critical and evidenced-based review.Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations.Nutraceuticals in the management of osteoarthritis : a critical review.Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants.Experimental pharmacology of glucosamine sulfate.DRUG THERAPY IN KNEE OSTEOARTHROSIS.Two Small RNAs Conserved in Enterobacteriaceae Provide Intrinsic Resistance to Antibiotics Targeting the Cell Wall Biosynthesis Enzyme Glucosamine-6-Phosphate Synthase.The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog.Glucosamine and chondroitin for the treatment of osteoarthritis.Glucosamine binding to proteins in plasma and synovial fluid and blood cell/plasma partitioning in mouse and man in vitro.In vitro study of the inhibition and induction of human cytochromes P450 by crystalline glucosamine sulfate.Combination of glucosamine improved therapeutic effect of low-dose cyclosporin A in patients with atopic dermatitis: a pilot study.Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).Precolumn derivatization LC-MS/MS method for the determination and pharmacokinetic study of glucosamine in human plasma and urine.Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs.Determination of Glucosamine in Human Plasma by High-Performance Liquid Chromatography-Atmospheric Pressure Chemical Ionization Source-Tandem Mass Spectrometry
P2860
Q21195259-0213E76C-8A1B-4B69-8B7A-F28FD74DDBB1Q21254655-37804721-E74F-4AFA-B0D1-D9B209ABC786Q24606203-4F9A27C8-1E58-4343-8D20-0C3E0FC28600Q24630640-068448F2-40AC-41AE-88E1-26F338FC6E75Q30235140-15B829EB-DE1E-4BCC-9635-C19E9602F732Q33368886-88D415DB-6C04-4FE2-BC00-C4E60B60F463Q33632751-ED9B3335-6BDB-4F2C-A00D-66675784716CQ33678954-CDE7A4AB-1533-4706-9748-8A9E1EC0B8FDQ33679221-FBD44640-B4E4-4E99-875E-679A17E298EEQ33827973-842C57E0-D746-4B78-8FC5-8009F3886059Q34517159-4181C53D-D1A9-4C45-926C-A4B8D0250F73Q34588403-72C016F4-1ED9-431C-8860-BFF52FC784BEQ34636799-321665BB-25D6-4CC9-9614-E711878A72F3Q34654013-043EF79C-8C6A-48C4-8666-F8A0818758B7Q35632646-CEA3F727-EC7B-460E-9EDE-E92E5AACFC3EQ36831445-E13B9400-397F-434F-86C5-3A0FFEDF348BQ37354339-6A15779A-CCC2-42E4-862C-74D1A0873E4AQ37523942-C6EFE3DD-80C7-4E06-B72F-7F0155FB7712Q37667284-4C12F42C-CACD-4F61-B539-BFCA6AE8E501Q37798321-D5DA9002-4B52-47E6-9AD7-D741CC4252E7Q37868775-2199714A-6755-4757-A5D6-5860C88B8516Q37960179-D2EECE84-E97B-47EF-86A4-4C5FD9BACDB4Q38047227-94262B9F-257F-43B9-B221-0E694CEE52EFQ38362244-46F865B0-1134-4E17-AA43-DD9F7ADAC072Q38684643-F53C1FFD-8CA4-40CA-9D38-087D1A556DFFQ38856377-4474AA4E-8138-40BC-BAB9-9885E0941EB0Q40625268-3AB036E2-6B94-45D3-959D-D67EE19C26CEQ41966032-F3F8D5C6-18A5-4075-84E8-D93F79E58D00Q42330053-887C0ED8-44FB-47C5-AC7F-DF07D3859DAEQ43090795-87D7E249-FBAF-4CFB-868F-FE2F7C1EA452Q43090797-D1AADE0A-CDFC-481D-8A89-0085901FD04BQ45797653-75315BDA-76EE-48DB-876E-6C18FF1A518FQ47151673-9C608E9D-ADCA-4CE1-8886-291091B3F920Q47816389-1DB9DEA7-4B07-4C72-8FF0-E66F9A210C17Q49742445-8F64A3EA-7F07-45BA-B849-B3C51AF070FFQ51392424-5417534A-A1CE-4676-BC30-C0E032CDF98DQ58655402-84A384F3-A316-43C4-9713-2BD6888A2F99
P2860
Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@ast
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@en
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@nl
type
label
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@ast
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@en
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@nl
prefLabel
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@ast
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@en
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@nl
P2093
P1476
Synovial and plasma glucosamin ...... sulphate at therapeutic dose.
@en
P2093
D Antonioli
D Paganini
G Trisolino
L C Rovati
M Locatelli
S Persiani
P304
P356
10.1016/J.JOCA.2007.01.019
P577
2007-03-13T00:00:00Z